ARWRNasdaqPharmaceutical PreparationsFiscal year ends September 30

ARROWHEAD PHARMACEUTICALS, INC.

Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026

$57.23+1.33 (+2.38%)

Close on Oct 19, 2026

Market cap: $8.21B
P/E (TTM): –
Dividend yield: –

ARROWHEAD PHARMACEUTICALS, INC. balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-09-30	FY 2024 2024-09-30	FY 2023 2023-09-30	FY 2022 2022-09-30	FY 2021 2021-09-30	FY 2020 2020-09-30	FY 2019 2019-09-30	FY 2018 2018-09-30	FY 2017 2017-09-30	FY 2016 2016-09-30	FY 2015 2015-09-30	FY 2014 2014-09-30	FY 2013 2013-09-30	FY 2012 2012-09-30	FY 2011 2011-09-30	FY 2010 2010-09-30	FY 2009 2009-09-30	FY 2008 2008-09-30	FY 2007 2007-09-30	FY 2006 2006-09-30
Cash & Equivalents	227	103	111	108	184	144	222	30	25	85	81	133	19	3.38	7.51	6.85	2.02	–	–	–
Short-Term Investments	693	578	293	0	127	85	–	–	–	–	–	22	9.03	0.11	0.63	–	–	–	–	–
Cash & Short-Term Investments	919	681	404	108	311	229	222	30	25	85	81	154	28	3.48	8.14	6.85	2.02	–	–	–
Receivables	6.82	0	0	1.41	10	0.85	0.66	0.33	0.07	0.08	–	–	0.08	0.01	–	0.06	–	–	–	–
Prepaid Expenses & Other	11	9.54	8.81	7.29	4.36	4.25	3.32	1.27	0.87	1.29	3.29	0.59	0.53	0.62	0.11	0.35	–	–	–	–
Other Current Assets	14	4.97	4.03	20	2.19	1.78	2.56	0.64	1.36	3.77	0.82	0.05	0.09	–	–	–	–	–	–	–
Total Current Assets	951	695	416	405	385	322	265	79	68	91	103	155	29	6.57	9.86	8.13	–	–	–	–
Property, Plant & Equipment	383	386	290	110	49	31	23	14	16	15	4.53	3.87	3.51	4.90	0.03	0.14	–	–	–	–
Gross Property, Plant & Equipment	463	444	332	142	72	47	35	24	23	20	9.99	8.06	6.59	6.46	0.37	1.32	–	–	–	–
Accumulated Depreciation	-80	-58	-42	-32	-23	-16	-12	-9.81	-7.09	-4.51	-5.46	-4.19	-3.08	-1.57	-0.34	-1.18	–	–	–	–
Land	–	–	3.00	3.00	0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Construction in Progress	–	–	167	56	0.35	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Long-Term Investments	–	–	–	–	–	–	–	–	–	–	–	23	1.70	–	–	–	–	–	–	–
Equity Method Investments	–	–	–	–	–	–	–	–	–	–	–	–	–	–	1.65	1.81	–	–	–	–
Operating Lease Right-of-Use Assets	44	45	45	58	17	16	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Intangible Assets	6.86	8.56	10	12	14	15	17	19	20	22	25	1.01	3.24	4.78	1.73	1.97	–	–	–	–
Other Long-Term Assets	1.39	4.48	3.26	0.22	0.27	0.26	0.14	0.14	0.14	0.12	0.05	–	4.97	5.06	6.00	4.08	–	–	–	–
Total Assets	1,385	1,140	766	692	710	523	350	112	104	128	132	183	37	17	16	12	–	–	–	–
Accounts Payable	18	11	36	2.87	9.46	6.83	7.65	2.81	4.08	12	5.03	2.58	1.20	0.88	0.58	0.68	–	–	–	–
Accrued Expenses	90	63	40	47	14	5.39	6.50	5.04	4.56	4.59	5.38	1.40	0.64	0.73	0.86	0.49	–	–	–	–
Current Portion of Leases	7.29	6.34	11	2.78	2.25	1.10	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Current Income Taxes Payable	21	0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Deferred Revenue (Current)	2.40	0	0.87	74	111	19	78	0.00	5.27	2.57	0.10	0.10	0.10	0.04	–	–	–	–	–	–
Other Current Liabilities	11	0.43	0.44	0	–	0.02	0.02	0.05	0.05	0.05	0.05	0.06	0.59	1.59	–	–	–	–	–	–
Total Current Liabilities	195	103	105	139	147	41	97	12	19	26	16	12	8.73	5.33	2.58	4.28	–	–	–	–
Long-Term Debt	–	–	–	–	–	–	–	2.10	2.33	2.53	–	–	0.05	0.84	0.61	–	–	–	–	–
Long-Term Leases	104	111	105	79	23	20	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Operating Lease Liabilities	111	117	115	82	26	21	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Other Long-Term Liabilities	–	–	–	0	–	–	–	0.20	0.20	0.20	0.20	0.26	0.16	0.27	0.14	–	–	–	–	–
Total Liabilities	882	949	478	274	301	61	106	16	23	33	23	17	12	7.72	3.32	4.28	–	–	–	–
Total Debt	–	–	–	–	–	–	–	2.10	2.33	2.53	–	–	0.05	0.84	0.61	–	–	–	–	–
Preferred Stock	–	–	–	–	–	–	–	–	–	0.00	0.00	0.00	0.00	–	–	–	–	–	–	–
Common Stock	0.23	0.22	0.20	0.20	0.20	0.20	0.19	0.18	0.17	0.16	0.15	0.15	0.12	0.11	0.09	0.07	–	–	–	–
Additional Paid-In Capital	2,140	1,806	1,300	1,219	1,053	965	664	583	514	494	427	391	194	146	127	120	–	–	–	–
Retained Earnings	-1,627	-1,626	-1,026	-821	-645	-504	-419	-487	-433	-398	-317	-225	-166	-135	-114	-111	–	–	–	–
Treasury Stock	-53	0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Comprehensive Income & Other	6.44	4.75	-3.22	-0.14	-0.07	0.02	-0.39	-0.02	0.03	0.01	-0.14	–	–	–	–	–	–	–	–	–
Shareholders' Equity	466	185	271	399	409	462	245	96	81	96	110	167	27	10	13	9.05	–	–	–	–
Noncontrolling Interest	37	5.62	16	20	0	–	-0.56	-0.56	-0.56	-0.56	-0.56	-0.56	-1.76	-1.20	-0.23	-0.97	–	–	–	–
Total Equity	503	191	287	418	409	462	244	95	81	95	110	166	26	8.81	13	8.08	4.86	12	26	32
Total Liabilities & Equity	1,385	1,140	766	692	710	523	350	112	104	128	132	183	37	17	16	12	–	–	–	–
Shares Outstanding(shares)	136	124	107	106	104	102	96	89	75	70	60	55	32	14	8.64	7.17	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: –
Operating margin: -33.8%
Net margin: -47.8%
Return on equity, FY2025: -0.5%

Financial strength

Current ratio: 5.90
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 19.3%

Valuation

P/E ratio: –
Price to sales: 12.26
Price to book: 17.63
Dividend yield: –